v3.26.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 2,514 $ 238,040,520 $ 45,789 $ (233,970,752) $ 4,118,071
Balance (in shares) at Dec. 31, 2024 2,514,499        
Issuance of common stock pursuant to At Market Issuance Sales Agreement $ 979 3,242,198     3,243,177
Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares) 978,105        
Issuance costs associated with sales of common stock pursuant to At Market Issuance Sales Agreement   (72,165)     (72,165)
Issuance of common stock to vendors $ 12 29,988     30,000
Issuance of common stock to vendors (in shares) 12,346        
Share-based compensation expense   163,112     163,112
Net loss       (5,653,244) (5,653,244)
Balance at Jun. 30, 2025 $ 3,505 241,403,653 45,789 (239,623,996) 1,828,951
Balance (in shares) at Jun. 30, 2025 3,504,950        
Balance at Mar. 31, 2025 $ 3,183 240,770,981 45,789 (236,922,020) 3,897,933
Balance (in shares) at Mar. 31, 2025 3,183,992        
Issuance of common stock pursuant to At Market Issuance Sales Agreement $ 322 545,313     545,635
Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares) 320,958        
Issuance costs associated with sales of common stock pursuant to At Market Issuance Sales Agreement   (12,154)     (12,154)
Share-based compensation expense   99,513     99,513
Net loss       (2,701,976) (2,701,976)
Balance at Jun. 30, 2025 $ 3,505 241,403,653 45,789 (239,623,996) 1,828,951
Balance (in shares) at Jun. 30, 2025 3,504,950        
Balance at Dec. 31, 2025 $ 10,086 250,287,382 45,789 (245,051,132) $ 5,292,125
Balance (in shares) at Dec. 31, 2025 10,086,130       10,086,130
Issuance of common stock pursuant to At Market Issuance Sales Agreement $ 11,539 6,026,279     $ 6,037,818
Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares) 11,538,661        
Issuance costs associated with sales of common stock pursuant to At Market Issuance Sales Agreement   (124,249)     (124,249)
Issuance of common stock to vendors $ 12 14,990     $ 15,002
Issuance of common stock to vendors (in shares) 12,688       12,688
Share-based compensation expense   237,180     $ 237,180
Net loss       (4,812,319) (4,812,319)
Balance at Jun. 30, 2026 $ 21,637 256,441,582 45,789 (249,863,451) $ 6,645,557
Balance (in shares) at Jun. 30, 2026 21,637,479       21,637,479
Balance at Mar. 31, 2026 $ 10,518 250,909,695 45,789 (247,876,097) $ 3,089,905
Balance (in shares) at Mar. 31, 2026 10,518,269        
Issuance of common stock pursuant to At Market Issuance Sales Agreement $ 11,115 5,517,426     5,528,541
Issuance of common stock pursuant to At Market Issuance Sales Agreement (in shares) 11,114,862        
Issuance costs associated with sales of common stock pursuant to At Market Issuance Sales Agreement   (106,507)     (106,507)
Issuance of common stock to vendors $ 4 4,996     5,000
Issuance of common stock to vendors (in shares) 4,348        
Share-based compensation expense   115,972     115,972
Net loss       (1,987,354) (1,987,354)
Balance at Jun. 30, 2026 $ 21,637 $ 256,441,582 $ 45,789 $ (249,863,451) $ 6,645,557
Balance (in shares) at Jun. 30, 2026 21,637,479       21,637,479